1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, B; Wang, H; Yao, S; Zhang, Z | 1 |
| Caveliers, V; D'huyvetter, M; Devoogdt, N; Heemskerk, J; Keyaerts, M; Lahoutte, T; Muyldermans, S; Vaneycken, I; Vincke, C; Xavier, C | 1 |
| Bérubé-Lauzière, Y; Guérin, B; Klarskov, K; Lebel, R; Lecomte, R; Ranyuk, E; van Lier, JE | 1 |
| Ali, IU; Chen, X; Huang, P; Jacobson, O; Kiesewetter, DO; Lang, L; Niu, G; Teng, G; Wang, Y; Wang, Z | 1 |
| Barnhart, TE; Cai, W; Chakravarty, R; Chen, F; Goel, S; Hernandez, R; Hong, H; Valdovinos, HF | 1 |
| Chen, Q; González Trotter, D; Haley, H; Lin, SA; Low, PS; McQuade, P; Meng, X; Miller, P; Rubins, D; Zeng, Z | 1 |
| Boerman, OC; Eek, A; Goldenberg, DM; Joosten, L; Laverman, P; McBride, WJ; Oyen, WJ; Sharkey, RM | 1 |
| Chung, JK; Jeong, JM; Ju, CH; Kim, YJ; Lee, DS; Lee, JY; Lee, MC; Lee, YS; Shetty, D | 1 |
| Dejesus, OT | 1 |
| Chen, X; Guo, N; Kiesewetter, DO; Lang, L; Li, W; Ma, Y; Niu, G; Shen, B; Zhu, L | 1 |
10 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Neoplasms
| Article | Year |
|---|---|
Preclinical evaluation of a dual sstr2 and integrin α
Topics: Animals; Cell Line, Tumor; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Mice, Nude; Neoplasms; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin | 2019 |
Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
Topics: Adult; Animals; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Stability; Female; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiometry; Rats; Receptor, ErbB-2; Reproducibility of Results; Single-Domain Antibodies; Tomography, X-Ray Computed | 2013 |
(68)Ga/DOTA- and (64)Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes.
Topics: Animals; Copper Radioisotopes; Fluorescent Dyes; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Indoles; Isoindoles; Mice; Mice, Nude; Neoplasms; Optical Imaging; Positron-Emission Tomography | 2013 |
In vivo albumin labeling and lymphatic imaging.
Topics: Albumins; Aluminum Compounds; Animals; Diagnostic Imaging; Evans Blue; Fluorescence; Fluorides; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Hindlimb; Image Processing, Computer-Assisted; Inflammation; Luminescent Measurements; Lymph Nodes; Lymphatic Vessels; Mice, Inbred BALB C; Multimodal Imaging; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Staining and Labeling | 2015 |
Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indoles; Mice, Nude; Nanoparticles; Neoplasms; Peptides, Cyclic; Porosity; Positron-Emission Tomography; Pyrroles; Silicon Dioxide; Sunitinib | 2015 |
Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Topics: A549 Cells; Animals; Female; Fluorine Radioisotopes; Folate Receptors, GPI-Anchored; Folic Acid; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; KB Cells; Mice; Mice, Nude; Neoplasms; Positron-Emission Tomography; Radiochemistry; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2016 |
A novel facile method of labeling octreotide with (18)F-fluorine.
Topics: Aluminum Chloride; Aluminum Compounds; Amino Acid Sequence; Animals; Buffers; Cell Line, Tumor; Chlorides; Drug Stability; Fluorine Radioisotopes; Gene Expression Regulation, Neoplastic; Halogenation; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Inhibitory Concentration 50; Isotope Labeling; Male; Mice; Neoplasms; Octanols; Octreotide; Rats; Receptors, Somatostatin; Somatostatin; Time Factors; Tissue Distribution; Water | 2010 |
Synthesis and evaluation of macrocyclic amino acid derivatives for tumor imaging by gallium-68 positron emission tomography.
Topics: Animals; Blood Proteins; Cell Line, Tumor; Chelating Agents; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Neoplasms; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals | 2010 |
Synthesis of [64Cu]Cu-NOTA-Bn-GE11 for PET imaging of EGFR-rich tumors.
Topics: Chromatography, High Pressure Liquid; Copper Radioisotopes; ErbB Receptors; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Neoplasms; Peptides; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice.
Topics: Animals; Cell Line, Tumor; Fluorine Radioisotopes; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Neoplasms; Oligopeptides; Positron-Emission Tomography | 2011 |